BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34754077)

  • 41. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.
    Wu J; Yin L; Jiang N; Guo WJ; Gu JJ; Chen M; Xia YY; Wu JZ; Chen D; Wu JF; Wang DJ; Zong D; Zhang N; Ding K; Huang T; He X
    Exp Cell Res; 2015 Nov; 338(2):232-8. PubMed ID: 26297956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis.
    Li YL; Zhang J; Min D; Hongyan Z; Lin N; Li QS
    PLoS One; 2016; 11(4):e0151502. PubMed ID: 27064569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression.
    Zhu H
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110249. PubMed ID: 32736275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma.
    He S; Yang S; Niu M; Zhong Y; Dan Gao ; Zhang Y; Ma H; Xiong W; Zhou M; Zhou Y; Xiang B; Li G; Shuai C; Peng S
    Cell Death Dis; 2018 Jan; 9(2):100. PubMed ID: 29367693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma.
    Liu Z; Long X; Chao C; Yan C; Wu Q; Hua S; Zhang Y; Wu A; Fang W
    BMC Cancer; 2014 Apr; 14():274. PubMed ID: 24751144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
    Sun FR; Wang SL; Wang M; Sun LM
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6726-6734. PubMed ID: 32633363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.
    Yang F; Qian XJ; Qin W; Deng R; Wu XQ; Qin J; Feng GK; Zhu XF
    PLoS One; 2013; 8(3):e59879. PubMed ID: 23533654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depletion of intermediate filament protein Nestin, a target of microRNA-940, suppresses tumorigenesis by inducing spontaneous DNA damage accumulation in human nasopharyngeal carcinoma.
    Ma J; Sun F; Li C; Zhang Y; Xiao W; Li Z; Pan Q; Zeng H; Xiao G; Yao K; Hong A; An J
    Cell Death Dis; 2014 Aug; 5(8):e1377. PubMed ID: 25118937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
    Fan CW; Tang J; Jiang JC; Zhou MM; Li MS; Wang HS
    Phytomedicine; 2022 Jul; 102():154192. PubMed ID: 35636179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.
    Chang L; Huang J; Wang K; Li J; Yan R; Zhu L; Ye J; Wu X; Zhuang S; Li D; Zhang G
    BMC Cancer; 2016 Mar; 16():190. PubMed ID: 26951044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
    Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
    J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.
    Sun Y; Hildesheim A; Li H; Li Y; Chen JY; Cheng YJ; Hayes RB; Rothman N; Bi WF; Cao Y
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):261-7. PubMed ID: 7606201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
    Yi C; Wang Q; Wang L; Huang Y; Li L; Liu L; Zhou X; Xie G; Kang T; Wang H; Zeng M; Ma J; Zeng Y; Yun JP
    Oncogene; 2012 Oct; 31(41):4421-33. PubMed ID: 22249270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Andrographolide, a diterpene lactone from the Traditional Chinese Medicine Andrographis paniculate, induces senescence in human lung adenocarcinoma via p53/p21 and Skp2/p27.
    Zhang J; Li C; Zhang L; Heng Y; Wang S; Pan Y; Cai L; Zhang Y; Xu T; Chen X; Hoffman RM; Jia L
    Phytomedicine; 2022 Apr; 98():153933. PubMed ID: 35121394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
    Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W
    BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.
    Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X
    Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma.
    Fan X; Wang Y; Song J; Wu H; Yang M; Lu L; Weng X; Liu L; Nie G
    Cancer Biol Ther; 2019; 20(10):1328-1336. PubMed ID: 31311404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mechanism of Hedyotis Diffusae Herba in the treatment of lupus nephritis based on network pharmacology.
    Yang J; Li S
    Front Pharmacol; 2023; 14():1118804. PubMed ID: 37361229
    [No Abstract]   [Full Text] [Related]  

  • 60. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
    Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J
    Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.